Delivery Order SPE2DB25D7067-SPE2DB25FSVGM
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $10,566.94. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a continuation of AmerisourceBergen's extensive federal pharmaceutical supply relationship. The contract was competitively awarded with no set-aside designation, consistent with the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,137.63. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $1,704.20 and an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Procainamide is an...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,505.03. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $3,164.53. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,508.11 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on August 27, 2025. This firm fixed price delivery order, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for procurement of Procainamide 1 gram/10 milliliter vials with a ceiling value of $5,235.21. This firm fixed price delivery order was awarded on May 20, 2025, with an ultimate completion date of May 21, 2025, and represents a non-competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a contract ceiling value of $4,296.26. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award represents...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $7,809.52 on September 16, 2025, for the supply of Procainamide 1 gram/10 mL vials (10 mL quantity). This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on September 17, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract does not utilize a set-aside...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Procainamide 1 gram/10 mL vials totaling $1,484.44. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 20, 2025, with performance to take place at the vendor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVGMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 23, 2025, for the supply of Procainamide 1,000 mg/2 ml vials with a ceiling value of $10,193.42 under a firm fixed-price arrangement. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 pharmaceutical prime vendor agreement running through December 2026. The contract requires performance completion by June 24, 2025, with fulfillment conducted from the company's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This procurement represents a routine medical supply delivery supporting the Defense Health Agency and military healthcare systems. Procainamide is a cardiac antiarrhythmic medication used in treating abnormal heart rhythms, reflecting the wide spectrum of pharmaceutical products that AmerisourceBergen supplies through its federal contracts. As a major pharmaceutical distributor with extensive experience fulfilling federal medical supply requirements, AmerisourceBergen leverages its DLA prime vendor agreement to provide on-demand delivery of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 6/23/25 |